FTIOP
PFE icon

Fiduciary Trust International of Pennsylvania’s Pfizer PFE Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$17.7M Sell
571,420
-107,629
-16% -$3.67M 0.83% 36
2019
Q4 		$33.4M Buy
679,049
+82,225
+14% +$2.93M 1.24% 21
2019
Q3 		$20.3M Sell
596,824
-6,433
-1% -$234K 0.81% 36
2019
Q2 		$24.8M Sell
603,257
-93,714
-13% -$3.72M 1.02% 26
2019
Q1 		$32.5M Sell
696,971
-35,646
-5% -$1.43M 1.39% 19
2018
Q4 		$34.7M Buy
732,617
+12,801
+2% +$531K 1.72% 13
2018
Q3 		$33.4M Buy
719,816
+1,773
+0.2% +$68.3K 1.39% 12
2018
Q2 		$28.1M Buy
718,043
+70,777
+11% +$2.42M 1.26% 17
2018
Q1 		$21.8M Sell
647,266
-14,513
-2% -$499K 1.01% 21
2017
Q4 		$22.7M Buy
+661,779
New +$22.6M 1.02% 22
2017
Q3 		– Sell
-672,609
Closed -$21.4M – 387
2017
Q2 		$21.4M Buy
672,609
+184,310
+38% +$5.81M 1.06% 23
2017
Q1 		$15.8M Sell
488,299
-4,900
-1% -$154K 1.19% 22
2016
Q4 		$15.2M Sell
493,199
-5,472
-1% -$167K 1.2% 20
2016
Q3 		$16M Sell
498,671
-5,201
-1% -$174K 1.29% 19
2016
Q2 		$16.8M Buy
503,872
+10,223
+2% +$326K 1.37% 19
2016
Q1 		$13.9M Buy
493,649
+1,205
+0.2% +$34.4K 1.18% 22
2015
Q4 		$15.1M Buy
492,444
+2,579
+0.5% +$81.1K 1.29% 22
2015
Q3 		$14.6M Sell
489,865
-169,418
-26% -$5.43M 1.36% 19
2015
Q2 		$21M Sell
659,283
-7,651
-1% -$249K 1.24% 16
2015
Q1 		$22M Buy
666,934
+5,361
+0.8% +$170K 1.42% 13
2014
Q4 		$19.6M Sell
661,573
-950
-0.1% -$27.2K 1.3% 18
2014
Q3 		$18.6M Buy
662,523
+2,843
+0.4% +$79.8K 1.28% 18
2014
Q2 		$18.6M Buy
659,680
+5,218
+0.8% +$149K 1.28% 20
2014
Q1 		$19.9M Buy
654,462
+317
+0% +$9.45K 1.46% 14
2013
Q4 		$19M Buy
654,145
+23,212
+4% +$676K 1.41% 14
2013
Q3 		$17.2M Buy
630,933
+7,118
+1% +$194K 1.41% 13
2013
Q2 		$16.6M Buy
+623,815
New +$17.2M 1.46% 12

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's PFE Position: Q1 2020 in Review

Fiduciary Trust International of Pennsylvania reduced its Pfizer (PFE) stake by 16% in Q1 2020, selling an estimated $3.67M and leaving 571,420 shares worth $17.7M. The position accounts for 0.83% of the portfolio, ranked #36.

Fiduciary Trust International of Pennsylvania first reported a position in PFE in Q2 2013 and has held it in 27 quarters since. The position peaked at $34.7M in Q4 2018. 2,438 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Fiduciary Trust International of Pennsylvania held 571,420 shares of Pfizer worth $17.7M as of Q1 2020.
  • Fiduciary Trust International of Pennsylvania sold 107,629 Pfizer shares in Q1 2020, an estimated $3.67M.
  • Pfizer made up 0.83% of Fiduciary Trust International of Pennsylvania's portfolio in Q1 2020, its #36 holding.
  • Fiduciary Trust International of Pennsylvania first reported a position in Pfizer in Q2 2013 and has held it in 27 quarters since.
  • Fiduciary Trust International of Pennsylvania's Pfizer position peaked at $34.7M in Q4 2018.
  • 2,438 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q1 2020, filed 27 Apr 2020.